Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Zhuanglong Xiao

Showing results (1-10 of 14) with videos related to

Pageof 2
Sort By:
BMC Gastroenterology|September 17, 2022
Utility of ascitic tumor markers and adenosine deaminase for differential diagnosis of tuberculous peritonitis and peritoneal carcinomatosisLi Du, Xiuqi Wei, Zhuanglong Xiao, et al.
International Journal of Molecular Sciences|August 26, 2023
Piezo1 in Digestive System Function and DysfunctionJing He, Xiaotian Xie, Zhuanglong Xiao, et al.
The American Journal of the Medical Sciences|June 16, 2024
Diagnostic algorithm based on ratio of ascites-serum tumor markers is superior to tumor markers in the differentiation of benign ascites from malignant ascitesMinghui Liu, Nan Zhang, Xiuqi Wei, et al.
Translational Cancer Research|March 14, 2024
Upregulation of RACGAP1 is correlated with poor prognosis and immune infiltration in hepatocellular carcinomaYangyang Zhou, Shimeng Zheng, Qihang Guo, et al.
Liver International : Official Journal of the International Association for the Study of the Liver|November 10, 2022
Enoxaparin attenuates pyrrolizidine alkaloids-induced hepatic sinusoidal obstruction syndrome by inhibiting oncostatin M expressionHongyu Xiang, Chang Liu, Zhuanglong Xiao, et al.
Biomedicines|May 4, 2026
Molecular Mechanisms of Zhizhu Kuanzhong Capsule in the Treatment of Co-Morbid Anxiety and Depression of Functional Dyspepsia: Network Pharmacology, Molecular Docking and In Vivo ValidationJing He, Ruiyun Wang, Pengcheng Yang, et al.
BMC Gastroenterology|January 22, 2022
MS275 as Class I HDAC inhibitor displayed therapeutic potential on malignant ascites by iTRAQ-based quantitative proteomic analysisLi Du, Dongyuan Wang, Xiuqi Wei, et al.
Cell & Bioscience|July 8, 2023
Gut microbiota-derived tryptophan metabolites alleviate liver injury via AhR/Nrf2 activation in pyrrolizidine alkaloids-induced sinusoidal obstruction syndromeHaitao Shang, Chao Huang, Zhuanglong Xiao, et al.
Cell Death Discovery|January 23, 2023
Interferon-γ secreted by recruited Th1 cells in peritoneal cavity inhibits the formation of malignant ascitesChang Liu, Zhuanglong Xiao, Li Du, et al.
Cell Death & Disease|April 7, 2020
Myofibroblast induces hepatocyte-to-ductal metaplasia via laminin-ɑvβ6 integrin in liver fibrosisTing Xu, Zhiwen Lu, Zhuanglong Xiao, et al.
Pageof 2

Showing results (1-10 of 14) with videos related to

Sort By:
Pageof 2
BMC Gastroenterology|September 17, 2022
Utility of ascitic tumor markers and adenosine deaminase for differential diagnosis of tuberculous peritonitis and peritoneal carcinomatosisLi Du, Xiuqi Wei, Zhuanglong Xiao, et al.
International Journal of Molecular Sciences|August 26, 2023
Piezo1 in Digestive System Function and DysfunctionJing He, Xiaotian Xie, Zhuanglong Xiao, et al.
The American Journal of the Medical Sciences|June 16, 2024
Diagnostic algorithm based on ratio of ascites-serum tumor markers is superior to tumor markers in the differentiation of benign ascites from malignant ascitesMinghui Liu, Nan Zhang, Xiuqi Wei, et al.
Translational Cancer Research|March 14, 2024
Upregulation of RACGAP1 is correlated with poor prognosis and immune infiltration in hepatocellular carcinomaYangyang Zhou, Shimeng Zheng, Qihang Guo, et al.
Liver International : Official Journal of the International Association for the Study of the Liver|November 10, 2022
Enoxaparin attenuates pyrrolizidine alkaloids-induced hepatic sinusoidal obstruction syndrome by inhibiting oncostatin M expressionHongyu Xiang, Chang Liu, Zhuanglong Xiao, et al.
Biomedicines|May 4, 2026
Molecular Mechanisms of Zhizhu Kuanzhong Capsule in the Treatment of Co-Morbid Anxiety and Depression of Functional Dyspepsia: Network Pharmacology, Molecular Docking and In Vivo ValidationJing He, Ruiyun Wang, Pengcheng Yang, et al.
BMC Gastroenterology|January 22, 2022
MS275 as Class I HDAC inhibitor displayed therapeutic potential on malignant ascites by iTRAQ-based quantitative proteomic analysisLi Du, Dongyuan Wang, Xiuqi Wei, et al.
Cell & Bioscience|July 8, 2023
Gut microbiota-derived tryptophan metabolites alleviate liver injury via AhR/Nrf2 activation in pyrrolizidine alkaloids-induced sinusoidal obstruction syndromeHaitao Shang, Chao Huang, Zhuanglong Xiao, et al.
Cell Death Discovery|January 23, 2023
Interferon-γ secreted by recruited Th1 cells in peritoneal cavity inhibits the formation of malignant ascitesChang Liu, Zhuanglong Xiao, Li Du, et al.
Cell Death & Disease|April 7, 2020
Myofibroblast induces hepatocyte-to-ductal metaplasia via laminin-ɑvβ6 integrin in liver fibrosisTing Xu, Zhiwen Lu, Zhuanglong Xiao, et al.
Pageof 2